Kemmian D. Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kemmian D. Johnson has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Hemant Goyal
The Wright Center for Graduate Medical Education, Scranton, USA
3 shared publications - Abhilash Perisetti
Division of Gastroenterology and Hepatology, Kansas City Veteran Affairs, Kansas City, MO 64128, USA
2 shared publications Benjamin Tharian
2 shared publicationsRagesh Thandassery
2 shared publicationsSumant Inamdar
2 shared publicationsAbhilash Perisetti
Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR, 72205, USA
1 shared publication
Latest Publications
- Open Access
- 19 May 2021
- Published by Maad Rayan Publishing Company in Health Promotion Perspectives
- Vol. 11 (2) , 179-185
Combatting a "Twin-demic": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients
Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September 2020 to December 2020. Intent to be vaccinated against the COVID-19 and influenza virus was assessed through a brief questionnaire. Additionally, hesitancy and attitudes regarding vaccines were ascertained using validated 5-point Likert scales. In total, 280 patients completed the questionnaire. Results: A total of 248 patients were included in the final analysis. Overall 167 (67%, 95% CI = 61.1-73.0%) of patients were unsure or did not intend to be vaccinated against COVID-19, while only 19.3% (95% CI = 14.4-24.5%) were unsure or did not intend to be vaccinated against the influenza vaccine. Reasons for COVID-19 vaccine hesitancy included concern regarding side effects, fear of getting sick from the vaccine, and the absence of vaccine recommendations from their doctor. Concerningly, African American patients demonstrated decreased likelihood of receiving the COVID-19 vaccine. Conclusion: This survey revealed that only 1 in 3 adults intended to be vaccinated against COVID-19, while 8 out of 10 adults intended to receive the influenza vaccine. Patients who intended on getting the COVID-19 vaccine were less likely to be African American. Given the degree of hesitancy against COVID-19 vaccination, a multifaceted approach to facilitate vaccine uptake that includes vaccine education, behavioral change strategies, and health promotion, is paramount.
- 19 May 2021
- Published by Maad Rayan Publishing Company in Health Promotion Perspectives
- Vol. 11 (2) , 179-185
Open AccessCombatting a "Twin-demic": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients
Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September 2020 to December 2020. Intent to be vaccinated against the COVID-19 and influenza virus was assessed through a brief questionnaire. Additionally, hesitancy and attitudes regarding vaccines were ascertained using validated 5-point Likert scales. In total, 280 patients completed the questionnaire. Results: A total of 248 patients were included in the final analysis. Overall 167 (67%, 95% CI = 61.1-73.0%) of patients were unsure or did not intend to be vaccinated against COVID-19, while only 19.3% (95% CI = 14.4-24.5%) were unsure or did not intend to be vaccinated against the influenza vaccine. Reasons for COVID-19 vaccine hesitancy included concern regarding side effects, fear of getting sick from the vaccine, and the absence of vaccine recommendations from their doctor. Concerningly, African American patients demonstrated decreased likelihood of receiving the COVID-19 vaccine. Conclusion: This survey revealed that only 1 in 3 adults intended to be vaccinated against COVID-19, while 8 out of 10 adults intended to receive the influenza vaccine. Patients who intended on getting the COVID-19 vaccine were less likely to be African American. Given the degree of hesitancy against COVID-19 vaccination, a multifaceted approach to facilitate vaccine uptake that includes vaccine education, behavioral change strategies, and health promotion, is paramount.
- 12 January 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (12) , 4090-4098
Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature
The etiology of most cases of liver diseases in pregnancy can be diagnosed with a thorough history, physical examination, laboratory values, serology, and noninvasive imaging. However, atypical clinical and laboratory presentations of liver diseases/chemistries require a liver biopsy to render an accurate diagnosis in cases where the biopsy results affect the timing of delivery or impact choice of medical therapy. According to the American College of Gastroenterology, liver biopsy can be effectively and safely conducted in pregnant women. Conventional routes of performing a liver biopsy include the percutaneous, transjugular route, and surgical methods. Endoscopic ultrasound-guided liver biopsy is a recent technique that has not yet gained widespread adoption but can potentially serve as an alternative route for obtaining the liver sample. Adverse events associated with liver biopsy include abdominal pain and hemorrhage. Maternal and fetal outcomes are limited to increased risk of preterm birth and small for gestational age neonate. However, very few studies have formally evaluated the safety of liver biopsy in pregnant women. In this review, we present two successful cases of liver biopsy performed during pregnancy and summarize the most recent evidence regarding the safety and outcomes of the procedure in pregnancy to assist clinicians in their decision to perform a liver biopsy during pregnancy or postpone it until after delivery.
- 12 January 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (12) , 4090-4098
Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature
The etiology of most cases of liver diseases in pregnancy can be diagnosed with a thorough history, physical examination, laboratory values, serology, and noninvasive imaging. However, atypical clinical and laboratory presentations of liver diseases/chemistries require a liver biopsy to render an accurate diagnosis in cases where the biopsy results affect the timing of delivery or impact choice of medical therapy. According to the American College of Gastroenterology, liver biopsy can be effectively and safely conducted in pregnant women. Conventional routes of performing a liver biopsy include the percutaneous, transjugular route, and surgical methods. Endoscopic ultrasound-guided liver biopsy is a recent technique that has not yet gained widespread adoption but can potentially serve as an alternative route for obtaining the liver sample. Adverse events associated with liver biopsy include abdominal pain and hemorrhage. Maternal and fetal outcomes are limited to increased risk of preterm birth and small for gestational age neonate. However, very few studies have formally evaluated the safety of liver biopsy in pregnant women. In this review, we present two successful cases of liver biopsy performed during pregnancy and summarize the most recent evidence regarding the safety and outcomes of the procedure in pregnancy to assist clinicians in their decision to perform a liver biopsy during pregnancy or postpone it until after delivery.
- 1 January 2020
- Published by AME Publishing Company in Journal of Laboratory and Precision Medicine
- Vol. 5, 4
Laboratory evaluation of deranged liver chemistries in pregnancy
Liver chemistries (LCs) serve as important noninvasive methods of assessing liver function, hepatocellular injury and cholestasis. In pregnant women, alterations in some LCs occur as a result of the normal physiologic changes of pregnancy. Despite this, majority of LCs including platelets, alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, gamma-glutamyl transpeptidase (GGT) and lactate dehydrogenase (LDH), remain within normal limits throughout the course of pregnancy. On the contrary, levels of alpha fetoprotein (AFP) and alkaline phosphatase are expected to rise. Similarly, the coagulation system undergoes significant changes, increasing production of clotting factors and reducing native anticoagulants, all which act to induce a prothrombotic state in preparation for the blood loss associated with delivery. It is, therefore, important to distinguish between laboratory changes associated with normal physiological changes and liver diseases in pregnancy. Abnormal LCs occur at an overall rate of 3–5% in pregnant women. Detection of these abnormalities in LC’s may indicate an underlying liver disease or disease process affecting the liver, which can have negative health implications for both the mother and unborn fetus. A classic approach to liver disease in pregnancy includes liver diseases that are unique to pregnant women, pre-existing liver diseases, and those emerging coincidentally during pregnancy. A variety of changes in LC’s are observed in liver disease in pregnancy, each with a unique pattern of derangements. This review summarizes the differential diagnosis and approach consideration for presentation of deranged LCs in pregnant women, while giving special emphasis to laboratory investigations.
- 1 January 2020
- Published by AME Publishing Company in Journal of Laboratory and Precision Medicine
- Vol. 5, 4
Laboratory evaluation of deranged liver chemistries in pregnancy
Liver chemistries (LCs) serve as important noninvasive methods of assessing liver function, hepatocellular injury and cholestasis. In pregnant women, alterations in some LCs occur as a result of the normal physiologic changes of pregnancy. Despite this, majority of LCs including platelets, alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, gamma-glutamyl transpeptidase (GGT) and lactate dehydrogenase (LDH), remain within normal limits throughout the course of pregnancy. On the contrary, levels of alpha fetoprotein (AFP) and alkaline phosphatase are expected to rise. Similarly, the coagulation system undergoes significant changes, increasing production of clotting factors and reducing native anticoagulants, all which act to induce a prothrombotic state in preparation for the blood loss associated with delivery. It is, therefore, important to distinguish between laboratory changes associated with normal physiological changes and liver diseases in pregnancy. Abnormal LCs occur at an overall rate of 3–5% in pregnant women. Detection of these abnormalities in LC’s may indicate an underlying liver disease or disease process affecting the liver, which can have negative health implications for both the mother and unborn fetus. A classic approach to liver disease in pregnancy includes liver diseases that are unique to pregnant women, pre-existing liver diseases, and those emerging coincidentally during pregnancy. A variety of changes in LC’s are observed in liver disease in pregnancy, each with a unique pattern of derangements. This review summarizes the differential diagnosis and approach consideration for presentation of deranged LCs in pregnant women, while giving special emphasis to laboratory investigations.
- 2 December 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (2) , 361-375
Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review
Endoscopic retrograde cholangiopancreatography (ERCP) is a well-known procedure with both diagnostic and therapeutic utilities in managing pancreaticobiliary conditions. With the advancements of endoscopic techniques, ERCP has become a relatively safe and effective procedure. However, as ERCP is increasingly being utilized for different advanced techniques, newer complications have been noticed. Post-ERCP complications are known, and mostly include pancreatitis, infection, hemorrhage, and perforation. The risks of these complications vary depending on several factors, such as patient selection, endoscopist’s skills, and the difficulties involved during the procedure. This review discusses post-ERCP complications and management strategies with new and evolving concepts.
- 2 December 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (2) , 361-375
Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review
Endoscopic retrograde cholangiopancreatography (ERCP) is a well-known procedure with both diagnostic and therapeutic utilities in managing pancreaticobiliary conditions. With the advancements of endoscopic techniques, ERCP has become a relatively safe and effective procedure. However, as ERCP is increasingly being utilized for different advanced techniques, newer complications have been noticed. Post-ERCP complications are known, and mostly include pancreatitis, infection, hemorrhage, and perforation. The risks of these complications vary depending on several factors, such as patient selection, endoscopist’s skills, and the difficulties involved during the procedure. This review discusses post-ERCP complications and management strategies with new and evolving concepts.
- 28 November 2019
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 43 (2) , 316-324
The difference between hypertension determined by self-report versus examination in the adult population of the USA: Continuous NHANES 1999–2016
Studies have considered the validity of self-reported hypertension relative to hypertension detected by examination; no study has explored trends in the difference between these two measures. Our objective was to calculate these differences overtime within subpopulations of the USA. We included non-Hispanic white, non-Hispanic black and Hispanic adults who participated in the National Health and Nutrition Examination Surveys from 1999 to 2016, in the analysis (N = 44 333). We subtracted self-reported hypertension from hypertension detected by examination to calculate blood pressure difference (BPD). We fit weighted linear regression models that included important covariates along with all combination of two- and three-way interactions to predict the BPD. We used the fitted lines of the models to depict the patterns of differences in the different subpopulations. Age ≥ 45 years, lack of annual clinical visit, body mass index (BMI) < 25 and time were important factors associated with increased BPD. People who are ≥ 45 years, have normal BMI, or do not have annual medical visits are more likely to have a bigger BPD. We can use the calculated BPD, to adjust estimates of the prevalence of self-reported hypertension.
- 28 November 2019
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 43 (2) , 316-324
The difference between hypertension determined by self-report versus examination in the adult population of the USA: Continuous NHANES 1999–2016
Studies have considered the validity of self-reported hypertension relative to hypertension detected by examination; no study has explored trends in the difference between these two measures. Our objective was to calculate these differences overtime within subpopulations of the USA. We included non-Hispanic white, non-Hispanic black and Hispanic adults who participated in the National Health and Nutrition Examination Surveys from 1999 to 2016, in the analysis (N = 44 333). We subtracted self-reported hypertension from hypertension detected by examination to calculate blood pressure difference (BPD). We fit weighted linear regression models that included important covariates along with all combination of two- and three-way interactions to predict the BPD. We used the fitted lines of the models to depict the patterns of differences in the different subpopulations. Age ≥ 45 years, lack of annual clinical visit, body mass index (BMI) < 25 and time were important factors associated with increased BPD. People who are ≥ 45 years, have normal BMI, or do not have annual medical visits are more likely to have a bigger BPD. We can use the calculated BPD, to adjust estimates of the prevalence of self-reported hypertension.
- 1 November 2016
- Published by SAGE Publications in Vector-Borne and Zoonotic Diseases
- Vol. 16 (11) , 696-702
Long-Term Nonmalignant Disease Mortality in Subjects Exposed to Transmissible Agents Present in Animals Used for Food
Objective: To study mortality from nonmalignant diseases in subjects with high exposure to transmissible agents present in animals used for food, and in their raw or inadequately cooked products. Methods: Mortality was compared in a cohort of meat handlers in slaughtering and processing plants with that of the U.S. general population. Results: Excess mortality was observed for conditions known to be associated with infections—these include, septicemia, chronic nephritis, diseases of the kidney and ureter, diseases of the pancreas, cirrhosis of the liver, acute and subacute endocarditis, acute rheumatic fever, functional diseases of the heart, aortic aneurysm, intracranial and intraspinous abscess, and meningitis. Excess mortality was also observed for ischemic heart disease and diabetes, conditions without an established infectious etiology, but which have been linked with infections. Conclusions: If transmissible agents present in food animals and their raw products cause long-term diseases and mortality in humans, this study importantly points to the likely diseases, many of which are already known to be associated with infections. The excess mortality observed for ischemic heart disease and diabetes is consistent with existing evidence linking these conditions with infections, and gives rise to the novel hypothesis that microbial agents present in food animals and their products may be candidates for an infective role in the occurrence of these conditions, and therefore needs further investigation.
- 1 November 2016
- Published by SAGE Publications in Vector-Borne and Zoonotic Diseases
- Vol. 16 (11) , 696-702
Long-Term Nonmalignant Disease Mortality in Subjects Exposed to Transmissible Agents Present in Animals Used for Food
Objective: To study mortality from nonmalignant diseases in subjects with high exposure to transmissible agents present in animals used for food, and in their raw or inadequately cooked products. Methods: Mortality was compared in a cohort of meat handlers in slaughtering and processing plants with that of the U.S. general population. Results: Excess mortality was observed for conditions known to be associated with infections—these include, septicemia, chronic nephritis, diseases of the kidney and ureter, diseases of the pancreas, cirrhosis of the liver, acute and subacute endocarditis, acute rheumatic fever, functional diseases of the heart, aortic aneurysm, intracranial and intraspinous abscess, and meningitis. Excess mortality was also observed for ischemic heart disease and diabetes, conditions without an established infectious etiology, but which have been linked with infections. Conclusions: If transmissible agents present in food animals and their raw products cause long-term diseases and mortality in humans, this study importantly points to the likely diseases, many of which are already known to be associated with infections. The excess mortality observed for ischemic heart disease and diabetes is consistent with existing evidence linking these conditions with infections, and gives rise to the novel hypothesis that microbial agents present in food animals and their products may be candidates for an infective role in the occurrence of these conditions, and therefore needs further investigation.